Português English

Referências

  1. American Academy of Family Physicians. Managing Hypertension Using Combination Therapy. Am Fam Physician. 2020;101(6):341-351. Acessado em 4 de agosto de 2025. https://www.aafp.org/pubs/afp/issues/2020/0315/p341.html
  2. American Academy of Family Physicians. Managing Chronic Hypertension in Pregnant Women: ACOG Releases Updated Practice Bulletin. Am Fam Physician. 2019;100(12):782-783. Acessado em 4 de agosto de 2025. https://www.aafp.org/pubs/afp/issues/2019/1215/p782.html
  3. American Academy of Family Physicians. ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria. Am Fam Physician. 2016;94(8):652. Acessado em 4 de agosto de 2025. https://www.aafp.org/afp/2016/1015/p652.html
  4. American College of Cardiology. 2023 ESH Hypertension Guideline Update: Bringing Us Closer Together Across the Pond. Publicado em 5 de fevereiro de 2024. Acessado em 4 de agosto de 2025. https://www.acc.org/Latest-in-Cardiology/Articles/2024/02/05/11/43/2023-ESH-Hypertension-Guideline-Update
  5. American Diabetes Association. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022;45(12):3075-3090. Acessado em 4 de agosto de 2025. https://diabetesjournals.org/care/article/45/12/3075/147614/Diabetes-Management-in-Chronic-Kidney-Disease-A
  6. American Heart Association. Medications Used to Treat Heart Failure. Acessado em 4 de agosto de 2025. https://www.heart.org/en/health-topics/heart-failure/treatment-options-for-heart-failure/medications-used-to-treat-heart-failure
  7. American Heart Association. Atrial Fibrillation Medications. Acessado em 4 de agosto de 2025. https://www.heart.org/en/health-topics/atrial-fibrillation/treatment-and-prevention-of-atrial-fibrillation/atrial-fibrillation-medications
  8. Asthma.net. What Are Beta Blockers and Are They Safe to Use With Asthma? Acessado em 4 de agosto de 2025. https://asthma.net/clinical/beta-blockers
  9. Bell DSH, Lutz A, Clements D. Management of the 'wicked' combination of heart failure and chronic kidney disease in the patient with diabetes. Diabetes Obes Metab. 2023;25(8):2110-2120. Acessado em 4 de agosto de 2025. https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.15181
  10. BVS Atenção Primária em Saúde. No tratamento da hipertensão, como realizar a escolha inicial e a progressão dos medicamentos anti-hipertensivos? Acessado em 4 de agosto de 2025. https://aps-repo.bvs.br/aps/no-tratamento-da-hipertensao-como-realizar-a-escolha-inicial-e-a-progressao-dos-medicamentos-anti-hipertensivos/
  11. BVS Saúde. Hipertensão arterial em afrodescendentes. Rev Soc Cardiol Estado de São Paulo. 2012;22(2):40-44. Acessado em 4 de agosto de 2025. https://pesquisa.bvsalud.org/portal/resource/pt/ses-29556
  12. Centers for Disease Control and Prevention. Products - Data Briefs - Number 364. Publicado em abril de 2020. Acessado em 4 de agosto de 2025. https://www.cdc.gov/nchs/products/databriefs/db364.htm
  13. Cleveland Clinic Journal of Medicine. ACE inhibitor and ARB therapy: Practical recommendations. Cleve Clin J Med. 2019;86(9):608-615. Acessado em 4 de agosto de 2025. https://www.ccjm.org/content/86/9/608
  14. CNN Brasil. Sociedade Brasileira de Cardiologia muda diretriz de diagnóstico de pressão alta. Acessado em 4 de agosto de 2025. https://www.cnnbrasil.com.br/saude/sociedade-brasileira-de-cardiologia-muda-diretriz-de-diagnostico-de-pressao-alta/
  15. CVRTI Utah. Ace Inhibitors vs Beta Blockers vs Angiotensin Receptor Blockers. Acessado em 4 de agosto de 2025. https://cvrti.utah.edu/heart-failure-therapy-ace-inhibitors-arbs-beta-blockers-cvrti/
  16. Departamento de Hipertensão Arterial da SBC. Tratamento da hipertensão arterial em grupos especiais. Acessado em 4 de agosto de 2025. http://departamentos.cardiol.br/dha/consenso3/capitulo6.asp
  17. Drugs.com. Propranolol Disease Interactions. Acessado em 4 de agosto de 2025. https://www.drugs.com/disease-interactions/propranolol.html
  18. EBSCO Research Starters. Thiazide diuretics (drug interactions). Acessado em 4 de agosto de 2025. https://www.ebsco.com/research-starters/complementary-and-alternative-medicine/thiazide-diuretics-drug-interactions
  19. European Society of Cardiology. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. E-Journal of Cardiology Practice. 2006;4(12). Acessado em 4 de agosto de 2025. https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-4/vol4n12-Title-Prevention-of-Atrial-Fibrillation-with-Angiotensin-Converting-E
  20. European Society of Cardiology. Cardio protective drugs: Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blockers (ARBs). Acessado em 4 de agosto de 2025. https://www.escardio.org/Education/ESC-Prevention-of-CVD-Programme/Treatment-goals/Cardio-Protective-drugs/angiotensin-converting-enzyme-inhibitors-ace-inhibitors-and-angiotensin-ii-rec
  21. Fagard RH, Celis H, Thijs L, Wouters S. Regression and progression of left ventricular hypertrophy in human hypertension: relation to achieved blood pressure. J Hypertens. 2009;27(7):1486-1491.
  22. Fournier A, Messerli FH, Achard JM, Fernandez L. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol. 2004;43(8):1343-1347.
  23. GoodRx. Classes of Drugs You May Need to Avoid With Asthma. Acessado em 4 de agosto de 2025. https://www.goodrx.com/conditions/asthma/class-of-drugs-to-avoid-with-asthma
  24. GoodRx. ACE Inhibitors vs. ARBs: Similarities, Differences, Interactions & More. Acessado em 4 de agosto de 2025. https://www.goodrx.com/conditions/hypertension/ace-inhibitors-vs-arbs-whats-the-difference
  25. Handler J. Managing hypertensive patients with gout who take thiazide. J Clin Hypertens (Greenwich). 2010;12(10):731-739. Acessado em 4 de agosto de 2025. https://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2010.00346.x
  26. HealthDirect Australia. Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). Acessado em 4 de agosto de 2025. https://www.healthdirect.gov.au/angiotensin-converting-enzyme-inhibitors-ace-and-angiotensin-receptor-blockers-arbs
  27. Healthline. Beta-Blockers and Asthma: Precautions, Safer Options, and More. Acessado em 4 de agosto de 2025. https://www.healthline.com/health/asthma/beta-blockers-and-asthma
  28. Heart and Stroke Foundation. Calcium channel blockers. Acessado em 4 de agosto de 2025. https://www.heartandstroke.ca/heart-disease/treatments/medications/calcium-channel-blockers
  29. Hypertension. What Is New in the ESC Hypertension Guideline? Hypertension. 2024;81(12):2564-2574. Acessado em 4 de agosto de 2025. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.23724
  30. Hypertension. What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension? Hypertension. 2024;81(12):2575-2585. Acessado em 4 de agosto de 2025. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.24173
  31. Hypertension. Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension. 2021;77(2):490-502. Acessado em 4 de agosto de 2025. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.16667
  32. JAMA Network Open. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction. JAMA Netw Open. 2024;7(4):e248274. Acessado em 4 de agosto de 2025. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2818870
  33. Journal of the American College of Cardiology. Race, Ethnicity, Hypertension, and Heart Disease: JACC Focus Seminar 1/9. J Am Coll Cardiol. 2021;78(24):2460-2470. Acessado em 4 de agosto de 2025. https://www.jacc.org/doi/10.1016/j.jacc.2021.06.017
  34. KDIGO. 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. Acessado em 4 de agosto de 2025. https://www.kidney-international.org/article/S0085-2538(20)31270-9/fulltext
  35. KDIGO. 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1-S127. Acessado em 4 de agosto de 2025. https://www.kidney-international.org/article/S0085-2538(22)00507-5/fulltext
  36. KDIGO. 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(1):117-314. Acessado em 4 de agosto de 2025. https://www.kidney-international.org/article/S0085-2538(23)00766-4/fulltext
  37. Medical News Today. Beta-blockers and COPD: Benefits, risks, and types. Acessado em 4 de agosto de 2025. https://www.medicalnewstoday.com/articles/beta-blockers-and-copd
  38. MedicineNet. Thiazide Diuretics (Water Pills): Drug List, Side Effects. Acessado em 4 de agosto de 2025. https://www.medicinenet.com/thiazide_diuretics-oral/article.htm
  39. MedicineNet. Beta-Blockers vs. Calcium Channel Blockers: Blood Pressure Drug Class Differences. Acessado em 4 de agosto de 2025. https://www.medicinenet.com/beta-blockers_vs_calcium_channel_blockers/drug-vs.htm
  40. Million Hearts. Improving Medication Adherence Among Patients with Hypertension. Acessado em 4 de agosto de 2025. https://millionhearts.hhs.gov/data-reports/factsheets/adherence.html
  41. National Center for Biotechnology Information. Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:389-403. Acessado em 4 de agosto de 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724277/
  42. National Center for Biotechnology Information. Management of Hypertension in Chronic Kidney Disease. Cardiol Clin. 2019;37(3):271-282. Acessado em 4 de agosto de 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC6422950/
  43. National Center for Biotechnology Information. Thiazide Diuretics - StatPearls. Atualizado em 2024. Acessado em 4 de agosto de 2025. https://www.ncbi.nlm.nih.gov/books/NBK532918/
  44. National Center for Biotechnology Information. Calcium Channel Blockers - StatPearls. Atualizado em 2024. Acessado em 4 de agosto de 2025. https://www.ncbi.nlm.nih.gov/books/NBK482473/
  45. National Kidney Foundation. ACE Inhibitors and ARBs. Acessado em 4 de agosto de 2025. https://www.kidney.org/kidney-topics/ace-inhibitors-and-arbs
  46. New England Journal of Medicine. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med. 2021;385(14):1268-1279. Acessado em 4 de agosto de 2025. https://www.nejm.org/doi/full/10.1056/NEJMoa2111437
  47. Pajewski NM, Williamson JD, Applegate WB, et al. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. J Am Geriatr Soc. 2020;68(3):496-504. Acessado em 4 de agosto de 2025. https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.16272
  48. PLOS Medicine. The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. PLoS Med. 2023;20(6):e1004223. Acessado em 4 de agosto de 2025. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004223
  49. PubMed. Factors Affecting Adherence to Antihypertensive Medication. Curr Hypertens Rep. 2018;20(11):96. Acessado em 4 de agosto de 2025. https://pubmed.ncbi.nlm.nih.gov/30384549/
  50. PubMed. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372:n189. Acessado em 4 de agosto de 2025. https://pubmed.ncbi.nlm.nih.gov/33568342/
  51. PubMed. Hyperuricemia Associated with Thiazide Diuretics in Hypertensive Adults. Curr Hypertens Rep. 2019;21(10):78. Acessado em 4 de agosto de 2025. https://pubmed.ncbi.nlm.nih.gov/31641556/
  52. PubMed. Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations. Cardiovasc Drugs Ther. 1988;2(2):177-189. Acessado em 4 de agosto de 2025. https://pubmed.ncbi.nlm.nih.gov/3154704/
  53. PubMed Central. The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases. Cardiovasc Drugs Ther. 2022;36(4):711-721. Acessado em 4 de agosto de 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC10397146/
  54. PubMed Central. Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies. BMC Cardiovasc Disord. 2014;14:148. Acessado em 4 de agosto de 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC4221690/
  55. PubMed Central. Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions. Int J Chron Obstruct Pulmon Dis. 2009;4:215-224. Acessado em 4 de agosto de 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699954/
  56. PubMed Central. Managing Hypertensive Patients With Gout Who Take Thiazide. J Clin Hypertens (Greenwich). 2021;23(12):2146-2152. Acessado em 4 de agosto de 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC8672996/
  57. Respiratory Research. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison. Respir Res. 2021;22(1):64. Acessado em 4 de agosto de 2025. https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-021-01661-8
  58. RxList. Blood Pressure Medications: 10 Types, List, Side Effects, Uses & Warnings. Acessado em 4 de agosto de 2025. https://www.rxlist.com/high_blood_pressure_hypertension_medications/drugs-condition.htm
  59. SciELO Brasil. V Diretrizes Brasileiras de Hipertensão Arterial. Arq Bras Cardiol. 2021;116(3):516-658. Acessado em 4 de agosto de 2025. https://www.scielo.br/j/abc/a/wHymbYzVmjY77q65x68QcdN
  60. SciELO Brasil. III Consenso Brasileiro de Hipertensão Arterial. Arq Bras Endocrinol Metabol. 1999;43(4):257-286. Acessado em 4 de agosto de 2025. https://www.scielo.br/j/abem/a/DqgfTzHLDkR4ZxXTp5V6bKv/
  61. ScienceDirect. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes. Int J Cardiol. 2017;231:111-115. Acessado em 4 de agosto de 2025. https://www.sciencedirect.com/science/article/abs/pii/S016752731630794X
  62. ScienceDirect. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials. J Am Coll Cardiol. 2006;47(1):93-101. Acessado em 4 de agosto de 2025. https://www.sciencedirect.com/science/article/pii/S0735109705012714
  63. ScienceDirect. Combining Other Antihypertensive Drugs With β-Blockers in Hypertension: A Focus on Safety and Tolerability. Can J Cardiol. 2014;30(5):S42-S46. Acessado em 4 de agosto de 2025. https://www.sciencedirect.com/science/article/pii/S0828282X13013676
  64. Springer. The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases. Cardiovasc Drugs Ther. 2022;36(4):711-721. Acessado em 4 de agosto de 2025. https://link.springer.com/article/10.1007/s10557-021-07248-1
  65. The Canadian Journal of Cardiology. β-Blockers and Atrial Fibrillation: Hypertension and Other Medical Conditions Influencing Their Use. Can J Cardiol. 2014;30(5):S28-S34. Acessado em 4 de agosto de 2025. https://onlinecjc.ca/article/S0828-282X(13)01558-4/fulltext
  66. WebMD. ACE Inhibitors and ARBs to Treat Atrial Fibrillation. Acessado em 4 de agosto de 2025. https://www.webmd.com/heart-disease/atrial-fibrillation/afib-treatments-ace-inhibitors-arbs
  67. Wikipedia. Antihypertensive. Acessado em 4 de agosto de 2025. https://en.wikipedia.org/wiki/Antihypertensive
  68. Wiley Online Library. Managing Hypertensive Patients With Gout Who Take Thiazide. J Clin Hypertens (Greenwich). 2010;12(10):731-739. Acessado em 4 de agosto de 2025. https://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2010.00346.x
  69. Wiley Online Library. Management of the 'wicked' combination of heart failure and chronic kidney disease in the patient with diabetes. Diabetes Obes Metab. 2023;25(8):2110-2120. Acessado em 4 de agosto de 2025. https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.15181
  70. Wiley Online Library. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. J Am Geriatr Soc. 2020;68(3):496-504. Acessado em 4 de agosto de 2025. https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.16272
Início